Application 050740
- Type
- NDA
- Sponsor
- ASTELLAS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | AMBISOME | AMPHOTERICIN B | INJECTABLE, LIPOSOMAL;INJECTION | 50MG/VIAL | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N050740-001 | AMBISOME | AMPHOTERICIN B | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N050740-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | RLD, RS | 1997-08-11 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | RLD, RS | 1997-08-11 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | RLD, RS | 1997-08-11 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | RLD, RS | 1997-08-11 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | RLD, RS | 1997-08-11 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | RLD, RS | 1997-08-11 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | RLD, RS | 1997-08-11 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | RLD, RS | 1997-08-11 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | RLD, RS | 1997-08-11 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N050740-001 | AMBISOME | 50MG/VIAL | INJECTABLE, LIPOSOMAL / INJECTION | AB | RLD, RS | 1997-08-11 | e64feba35796… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N050740-001 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N050740-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050740-001 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N050740-001 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050740-001 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050740-001 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050740-001 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050740-001 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050740-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050740-001 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N050740-001 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050740-001 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050740-001 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N050740-001 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N050740-001 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N050740-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N050740-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N050740-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-03-09 01:35 UTC | 2022-03 | N050740-001 | AB | 1 | bb7c543d1eb4… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N050740-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | N050740-001 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | N050740-001 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N050740-001 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N050740-001 | AB | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N050740-001 | AB | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N050740-001 | AB | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N050740-001 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N050740-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N050740-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N050740-001 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N050740-001 | AB | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N050740-001 | AB | 1 | cb3db0bc1861… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N050740-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amphotericin B | AMPHOTERICIN B | Sun Pharmaceutical Industries, Inc. | 02aadef1-390b-4270-b56d-33452eb89dde | 2026-04-20 | Warnings, Adverse reactions | AMPHOTERICIN B |
| Amphotericin B | AMPHOTERICIN B | Sun Pharmaceutical Industries, Inc. | 593cffa0-c305-48b6-8ec7-331e0ff91d2b | 2026-04-20 | Warnings, Adverse reactions | AMPHOTERICIN B |
| Amphotericin B | AMPHOTERICIN B | Eugia US LLC | 6f24975c-5191-4fc2-a8da-e57358f8e154 | 2025-06-12 | Warnings, Adverse reactions | AMPHOTERICIN B |
| Amphotericin B | AMPHOTERICIN B | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2b2f3ff5-9d62-4ad2-8eac-1181e5911513 | 2025-06-03 | Warnings, Adverse reactions | AMPHOTERICIN B |
| Amphotericin B | AMPHOTERICIN B | XGen Pharmaceuticals DJB, Inc. | a0a54943-9ce4-4f3e-b681-a1a9144c16ce | 2022-01-03 | Boxed warning, Warnings, Adverse reactions | AMPHOTERICIN B |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0469-3051 | AmBisome | amphotericin B | Astellas Pharma US, Inc. | NDA | Current |
| 0469-3051 | AmBisome | amphotericin B | Astellas Pharma US, Inc. | NDA | Current |
| 0469-3051 | AmBisome | amphotericin B | Astellas Pharma US, Inc. | NDA | Current |
| 0469-3051 | AmBisome | amphotericin B | Astellas Pharma US, Inc. | NDA | Current |
| 0469-3051 | AmBisome | amphotericin B | Astellas Pharma US, Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 80181 | SUPPL | 2024-11-07 |
| 80173 | SUPPL | 2024-11-05 |
| 69290 | SUPPL | 2021-11-10 |
| 66098 | SUPPL | 2021-02-05 |
| 66097 | SUPPL | 2021-02-05 |
| 62949 | SUPPL | 2020-05-13 |
| 62942 | SUPPL | 2020-05-13 |
| 8152 | SUPPL | 2012-03-13 |
| 18151 | SUPPL | 2012-03-09 |
| 22212 | ORIG | 2009-06-19 |
| 39221 | SUPPL | 2008-11-07 |
| 30417 | SUPPL | 2008-10-14 |
| 42711 | SUPPL | 2004-05-27 |
| 18150 | SUPPL | 2003-09-26 |
| 30416 | SUPPL | 2003-09-25 |
| 42710 | SUPPL | 2003-07-31 |
| 18149 | SUPPL | 2000-07-18 |
| 8151 | SUPPL | 2000-07-18 |
| 18148 | SUPPL | 2000-01-28 |
| 8150 | SUPPL | 2000-01-28 |